ArticleNeuro-oncology2026

An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survival.

Kyle S Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.